See All Slides - tctmd.com

Slides

Presentation TCT 2013

The Compelling Case for Innovation in Emerging Markets and Reverse Innovation

Presenter: Peter Fitzgerald

October 28, 2013

Presentation TCT 2013

Challenging Reimbursement Considerations for TAVR in the United States

Presenter: Wilson Szeto

October 28, 2013

Presentation

Top 5 Reasons for Using BVS

Presenter: B. Chevalier

December 02, 2013

Presentation

Utilzation of the Non Invasive Cardiac System (NICaS) in the ICU setting

Presenter: Shaul Lev

December 02, 2013

Presentation CTO 2014

TAP is my Routine 2 Stent Technique: Why and How to (with Case Examples)

Presenter: David G. Rizik

March 01, 2014

Presentation CTO 2014

Other 2 Stent Techniques: When to Use Minicrush, Culotte, SKS, and V Stenting (with Case Examples)

Presenter: Antonio Colombo

March 01, 2014

Presentation

Efficacy of a Minicourse in Radiation-Reducing Techniques in Invasive Cardiology

Presenter: Eberhard Kuon

March 20, 2014

Presentation ISET 2014

CREST 2: What Could It Tell Us?

Presenter: Thomas Brott

January 19, 2014

Presentation ISET 2014

Next Generation Stents: How Will They Be Used?

Presenter: Mahmood Razavi

January 21, 2014

Presentation ACC 2014

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Presenter: Philippe Généreux

March 30, 2014

Advertisement

Slides

The Compelling Case for Innovation in Emerging Markets and Reverse Innovation

Challenging Reimbursement Considerations for TAVR in the United States

Top 5 Reasons for Using BVS

Utilzation of the Non Invasive Cardiac System (NICaS) in the ICU setting

TAP is my Routine 2 Stent Technique: Why and How to (with Case Examples)

Other 2 Stent Techniques: When to Use Minicrush, Culotte, SKS, and V Stenting (with Case Examples)

Efficacy of a Minicourse in Radiation-Reducing Techniques in Invasive Cardiology

CREST 2: What Could It Tell Us?

Next Generation Stents: How Will They Be Used?

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content